Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MDD Market Snapshot: Depressing Future For Antidepressants

Related Content

AstraZeneca Pays $200M Upfront For Global Rights To Targacept's MDD Candidate

Dec 03 2009

Clinical Data Obtains Viibryd Approval In U.S.

Jan 24 2011

Chantix Banned For Pilots; Watchdog Report Cites More Risk

May 21 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window